Novartis AG at ASCO Investor Meeting (Virtual) Transcript
Please welcome from investor relations , Sloan Simpson.
Hi, everyone. Thank you so much for joining us at the Novartis Investor event at ASCO 2023. Welcome to everyone in the room and also to those who are with us online. We realize it's quite late for those in Europe so really appreciate your being with us.
We are excited to share the Kisqali data from the Phase III NATALEE study in early breast cancer, talk a bit about the opportunity that we see there. But first, a couple of housekeeping notes.
So we'll have a presentation, obviously, followed by Q&A. We'll take questions from the room but the people online can also submit questions. We'll read them out for you here in the room. Please just make sure to wait for the mic and to say your name before asking your question. We will try to wrap up here the presentation and Q&A by about 8:15 so we can have our reception afterwards.
With us today, we have Shreeram Aradhye, who is the President
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
